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SCOPE OF THE JOURNAL
The Journal of Vascular Surgery is dedicated to
the science and art of vascular surgery and aims to
improve the management of patients with vascular
diseases by publishing relevant papers that report
important medical advances, test new hypotheses,
and address current controversies. To achieve this
goal, the Journal will publish original clinical and
laboratory studies and reports and papers that com-
ment on the social, economic, ethical, legal, and
political factors that relate to these aims.
PEER REVIEW
Principles of peer review
Objectives. The purpose of peer review is to help
ensure that the published papers are of the highest
quality by (1) advising the editors on the originality
of the work, its importance relative to what has
already been published in the current literature, its
relevance to the objectives of the Journal, its scien-
tific creditability, and its acceptability for publica-
tion, given the space that is available; and (2) by
suggesting changes and providing advice and assis-
tance to the authors on important aspects that may
improve their manuscript.
Fairness. The success of peer review requires that
all reviewers exercise careful scientific judgment, be
impartial and equitable, and form a balanced view of
the content of each manuscript. There is no formu-
la that can guide the reviewers in this task, apart
from the requirement to be objective and fair.
Confidentiality. All documents and information
provided for the purpose of peer review must be
kept entirely confidential. Unauthorized access to
papers must be prevented by storing them in a
secure manner. The documents must not be shared
with other colleagues. If a reviewer wishes to seek a
colleague’s opinion on the scientific merit of a man-
uscript, the Editors must be consulted first, and the
colleague must adhere to the same standards of con-
fidentiality.
The manuscript must not be photocopied. When
the review is completed, the documents must be
destroyed or returned to the Journal office.
Any inquiries received by individual reviewers
about a manuscript should be referred to the
Editors.
Conflict of interest. The decisions of the
Editors must be fair and objective and they must
be seen to be impartial. Because the final decision
on publication rests with the Editors, their deci-
sions must not be influenced by the Joint Council
of The Society for Vascular Surgery and the North
American Chapter of the International Society for
Cardiovascular Surgery, the affiliated vascular
societies, or representatives of companies, adver-
tisers, government, or others who have conflicts of
interest.
Reviewers must decline to review any manuscript
applications with which they may have a conflict of
interest and should avoid reviewing any manuscript
if circumstances exist that could be viewed as affect-
ing their impartiality. For example, a reviewer
should not review a manuscript submitted by a close
personal friend, individuals from his or her institu-
tion, individuals with whom the reviewer has collab-
orated, or a scientist with whom the reviewer has
had long-standing scientific or personal differences.
When the reviewer is uncertain as to whether a con-
flict exists, he or she should inform the Editor of the
circumstances and the Editor will make the final
decision.
The peer review process. Fewer than half of the
manuscripts received by the Journal can be pub-
lished. The editors and reviewers, by providing
prompt and authoritative review, aim to optimize
the quality of the published papers.
All submitted manuscripts are reviewed initially
by the Editor-in-Chief, Senior Editor, and/or an
Associate Editor. A submission may be rejected out-
right if at least two of the Editors conclude that it
does not have sufficient merit to warrant publica-
tion.
Other manuscripts will be sent to two or three
members of the editorial board or to other expert
consultants for external peer review. The identities
of these reviewers are kept confidential. Reviewers
are asked to give the editors a confidential opinion
on the importance, originality, and scientific merit
of the manuscript; rank its importance relative to
what has already been published in the medical lit-
erature; and suggest changes that will improve the
paper.
A formal statistical review will be obtained to
ensure that the study population was clearly defined,
that the design of the study was suitable, that appro-
priate statistical methods were used, and that the
subsequent conclusions were supported by the data
and their analysis.
If two manuscripts are received on the same sub-
ject, unless both can be accommodated in the
Journal, priority in the review process will be given
to the manuscript that was submitted first as deter-
mined by the postmark. The editor will promptly
contact the authors of the second manuscript to
inform them of the problem and give them the
option of submitting their manuscript to another
journal.
Administrative issues related to peer review.
Authors are expected to comply with the published
Information for Authors. The Journal’s require-
ments for submission of a manuscript are in accor-
dance with the “Uniform Requirements for a
Manuscript Submitted to Biomedical Journals”
published in JAMA 1997;277:927-34. Failure to
adhere to these guidelines may negatively influence
the opinions of the editors and reviewers, and thus
the manuscript may be returned to the author for
appropriate revisions in organization before it is sent
out for peer review.
The editors will convey the final decision on the
disposition of the manuscript to the designated cor-
responding author along with the reasons for the
decision and the complete or summarized com-
ments from the reviewers.
If revisions are requested, the editor expects the
authors to revise the manuscript appropriately and
promptly to meet publication deadlines. The
authors must clearly indicate the changes that have
been made and/or explain their difference of opin-
ion with the reviewers.
At the completion of the peer review process, the
copies of the submitted manuscript will not be
returned to the authors. If the paper is rejected, the
figures will be returned on request.
The editors will send the reviewers a notification
of their final decision on the disposition of a manu-
script and, when appropriate to the review process,
the comments of other reviewers.
All manuscripts and correspondence will be kept
on file for a reasonable period of time before being
destroyed so that questions that may arise can be
answered.
TRANSFER OF COPYRIGHT OWNERSHIP
TO THE JOURNAL
Before a manuscript can be published, the
authors must provide a signed agreement transfer-
ring, assigning, or conveying all copyright owner-
ship of their manuscript to The Society for Vascular
Surgery and the North American Chapter,
International Society for Cardiovascular Surgery.
Hence, manuscripts accepted for publication
become the permanent property of the societies and
may not be published elsewhere by the authors
without written permission from the Journal. The
authors must sign the following statement. “The
undersigned author(s) transfer(s), assign(s), or oth-
erwise convey(s) all copyright ownership of the
manuscript to The Society for Vascular Surgery and
the North American Chapter, International Society
for Cardiovascular Surgery, in the event the work or
a revised version is published in the Journal of
Vascular Surgery.” If the work is not accepted by the
Journal, this agreement becomes null and void.
Manuscripts written by employees of the federal
government during the course of their official duties
may not be copyrightable. A separate attached letter
should explain this circumstance.
Subsequent to acceptance for publication, if the
authors withdraw their manuscript, the Journal may
make appropriate charges to cover the production
costs incurred.
Copies of the copyright document will be kept
indefinitely.
An individual may make a single photocopy of a
paper for his or her personal use, but multiple copies
cannot be made without the written permission of
the Journal or from the Copyright Clearance
Center.
ORIGINALITY OF MANUSCRIPT
The authors must certify that their article is orig-
inal, has not been published previously, and is not
under consideration for publication by another jour-
nal.
The authors must sign the following statement.
“The undersigned author(s) warrant(s) that the arti-
cle is original in form and substance, a manuscript of
similar content has not been published in print or
digital medium under my (our) authorship, does not
infringe upon any copyright or other proprietary
right of any third party, and is not under considera-
tion by another journal.”
Previous presentations and abstracts. If the
work has been presented previously at a meeting as
an oral presentation or poster or has been published
in an abstract, a detailed report will be considered
for publication. However, the authors are expected
to submit the details of the previous presentations
and provide the abstracts. In general, manuscripts
will not be considered if the work had been pub-
lished previously in full-length conference proceed-
ings or as a book chapter.
Major update of a previous study. If the sub-
mitted manuscript is a major update on the results
of a previously published study, the authors must
submit copies of the previous papers so that the edi-
tors can determine whether the new paper provides
significant new information or statistical power to
warrant publication.
Media releases. The editors recognize that news
organizations have the right to disseminate informa-
tion that may have been obtained from a presenta-
tion at a scientific meeting or through direct discus-
sions with the author. It is the author’s responsibility
to inform the editors that the work has been report-
ed previously by a journalist and explain the circum-
stances. In doing so, the authors should supply the
editors with the original media report.
If the results of the study may potentially have a
major impact on patient management, the authors
can request the Editor’s consideration of prompt
review and publication.
Once submitted to the Journal, discussion of the
contents of a manuscript with the media must be
delayed until the publication date of the paper unless
the editors provide prior approval. If the authors
provide additional information to the media during
the peer-review or publication process, the article
may be rejected or withdrawn from publication.
In some instances, the editors may ask the
authors to prepare a brief press release summarizing
the manuscript. However, as with all papers, further
discussion of the results with the media must be
deferred until the date of publication.
Multiple publication. A joint publication or sec-
ondary publication of a full-length paper in another
journal may be considered if the manuscript con-
tains very important information that deserves to be
disseminated to a significantly different readership
than that of the Journal. The editors of the Journal
may grant permission for secondary publication in
another journal if the original report in the Journal
is appropriately acknowledged and the secondary
publication follows the initial publication in the
Journal. Abstracts or full-length summaries of
papers presented at meetings may be published
simultaneously in another journal with permission
of the editors of both journals providing an appro-
priate acknowledgment is made in each journal.
AUTHORSHIP
It is not appropriate to include an individual as an
author unless he or she has made a significant con-
tribution to the conception or completion of the
manuscript and is willing to share the responsibility
for the content of the paper. Specifically, each of the
authors should have made a direct and substantial
contribution to the following areas: (1) conceiving
and designing the study and/or analyzing and inter-
preting the data; (2) writing the manuscript or pro-
viding critical revisions that are important for the
intellectual content; and (3) approving the final ver-
sion of the manuscript.
Each of the authors will be expected to sign an
authorship statement as follows. “The undersigned
author(s) certifies (certify) that I (we) have made a
direct and substantial contribution to the work
reported in the manuscript by participating in the
following areas: conceiving and designing the study
and/or analyzing and interpreting the data; writing
the manuscript or providing critical revisions that
are important for the intellectual content; and
approving the final version of the manuscript. I (we)
have participated to a sufficient degree to take pub-
lic responsibility for the work and believe the manu-
script describes truthful facts.”
If an author has collaborated in a project but does
not meet all the requirements for authorship, he or
she should be recognized in the acknowledgment
section of the manuscript.
The order of the authors’ names is at the discre-
tion of the coauthors, who may wish to add a foot-
note explaining the order of authorship and/or
their contributions.
ORIGINAL DATA
The authors must be prepared to provide their
original data for review by the editors and/or
reviewers if requested. Each author must sign the
following statement. “I (we) declare that I (we) shall
produce the data on which the manuscript is based
for examination by the editors or their assignees,
should they request it.”
The authors are responsible for keeping their orig-
inal data and experimental notes on file for a reason-
able period of time in case a question should arise
about the manuscript after it has been published.
The authors should consider including a footnote
in the manuscript indicating their willingness to
make the original data available to other investiga-
tors through electronic media to permit alternative
analysis and/or inclusion in meta-analysis.
AUTHORS’ DISCLOSURE OF CONFLICT
OF INTEREST
The authors’ university, institutional, and/or cor-
porate affiliations will be acknowledged on the title
page along with sources of funding. In addition, the
Journal expects the authors to disclose any commer-
cial associations that might represent a conflict of
interest in respect to the manuscript.
If a company’s product is mentioned in a manu-
script or other articles, including letters to the edi-
tor and editorials, all authors are expected to declare
whether they have a consulting or employment
arrangement or a royalty or stock agreement with
the company. The authors must sign the following
statement. “I (we) do not have any paid or unpaid
consulting, employment, royalty, stock, patent
agreement, position or other financial relationship
with any individual, company, organization with a
vested interest in the subject matter mentioned in
the manuscript except as disclosed below in an
attached statement.”
During the review process, this relationship will
be held in confidence. However, if the work is
accepted for publication, the editors and the
author(s) will discuss the extent of disclosure that is
appropriate to reveal to the readership. Disclosure of
such significant relationships will appear as an anno-
tation to the published manuscript.
ETHICAL AND ANIMAL EXPERIMENTA-
TION APPROVAL
Human subjects. Manuscripts that involve
research conducted on human subjects must include
a statement in the Methods section that the experi-
mental protocol and informed consent were approved
by the Institutional Review Board and that all subjects
gave informed consent. The editors reserve the right
to reject a manuscript if the authors fail to make these
statements in the manuscript or if, at the request of
the Editor, they do not provide appropriate docu-
mentation that their studies had appropriate approval
by their Institutional Review Board and that
informed consent was obtained from each patient.
Animal experiments. Manuscripts that report
animal experiments must include a statement in the
Methods section that the study was approved by the
Institutional Review Board and that the animal care
complied with the Guide for the Care and Use of
Laboratory Animals, Institute of Laboratory Animal
Resources, Commission on Life Sciences, National
Research Council. Washington: National Academy
Press, 1996.
CONSENT TO REPRODUCE PREVIOUSLY
PUBLISHED DATA
It is the authors’ responsibility to obtain written
consent from the copyright owner and the original
author to reproduce direct quotations, tables, or
illustrations that have appeared in copyrighted mate-
rial and to provide complete information regarding
their source. Similarly, permission must be obtained
for tables and figures that have been modified from
other publications.
PATIENT CONSENT FOR REPRODUCING
PHOTOGRAPHS AND CASE HISTORIES
Photographs of identifiable persons must be
accompanied by signed releases from patients or
from both living parents or guardians of minors.
Similarly, consent must be obtained if a person
can be identified from the case description.
COPYEDITING
A manuscript that is accepted for publication is
subject to copyediting so that it will conform to the
Journal’s standards and style. The revised manu-
script will be returned to the authors for approval.
By approving the changes, the authors accept the
responsibility for the changes made in their manu-
script by the copy editor.
SEQUENCE OF PUBLICATION
In general, manuscripts are published in the
order they are received, providing that the Journal
receives revisions in a timely fashion. Also, subject to
the same limitations, every effort is made to publish
the manuscripts presented at the annual meeting of
The Society for Vascular Surgery and North
American Chapter of the International Society for
Cardiovascular Surgery and from the affiliated soci-
eties as a group.
Under unusual circumstances, a paper may be
assigned priority for early publication if, in the view
of the Editors, it contains important new informa-
tion that should be brought to the attention of the
readers immediately.
PUBLISHED DISCUSSIONS
The discussions of papers presented at The
Society for Vascular Surgery and the North
American Chapter, International Society for
Cardiovascular Surgery and at some of the meetings
of the affiliated societies will be published with the
manuscripts; however, these discussions are subject
to editorial review and only those that enhance the
text or present alternative views will be published.
SCIENTIFIC MISCONDUCT
Misconduct in science was defined by the
National Academy of Sciences, National Academy of
Engineering, and the Institute of Medicine in 1992
as fabrication (ie, making up) of data or results, fal-
sification (ie, changing) of data or results, or plagia-
rism (ie, unauthorized use of the words, data, or
ideas of another person without giving appropriate
credit) in proposing, performing, or reporting
research. Misconduct in science does not include
errors in the scientific method or in experimental
design or data interpretation.
In dealing with alleged scientific misconduct, the
appropriate steps in the process include informing
the authors of the allegations, requesting clarifica-
tion, determining whether the misconduct did or
did not occur, and, to the extent possible, establish-
ing the intent, ascertaining whether there were mit-
igating factors, and making recommendations for
appropriate action.
If a charge of scientific misconduct appears to be
justified, it is the editors’ responsibility to refer the
matter to the appropriate individual at the authors’
university or institution where the work was done. 
The university or institution has the responsibili-
ty to investigate alleged scientific misconduct.
If the charge of scientific misconduct is substan-
tiated, the Journal will print a retraction and may
impose sanctions that could include a restriction on
future publication in the Journal. The decision to
issue a retraction generally must be made by the
authors and/or the appropriate authorities at the
university or institution who have access to the full
details of the investigation. A published retraction
will include the title of the original article, the same
first author as in the original paper, the reasons why
the article is being retracted, the circumstances of
the case, and a bibliographic reference to the origi-
nal paper. The retraction will be listed under a sepa-
rate heading in the Table of Contents.
CORRECTION OF ERRORS
As part of scientific process, errors may be dis-
covered after publication that require clarification,
correction, or retraction of the paper. The editor
will handle errors on an individual basis after discus-
sion with the authors.
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